Wolverine Trading
NVNO

Wolverine Trading’s enVVeno Medical NVNO Stock Holding History

Wolverine Trading’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$17.2K Buy
524
+202
+63% +$20.6K ﹤0.01% 5544
2025
Q2 		$45.8K Buy
+322
New +$38.1K ﹤0.01% 4365

Other funds holding NVNO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wolverine Trading's NVNO Position: Q3 2025 in Review

Wolverine Trading increased its enVVeno Medical (NVNO) stake by 63% in Q3 2025, buying an estimated $20.6K and bringing the position to 524 shares worth $17.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5544.

Wolverine Trading first reported a position in NVNO in Q2 2025 and has held it in 2 quarters since. The position peaked at $45.8K in Q2 2025. 36 funds tracked by Wall St. Rank hold NVNO as of Q3 2025.

  • Wolverine Trading held 524 shares of enVVeno Medical worth $17.2K as of Q3 2025.
  • Wolverine Trading bought 202 enVVeno Medical shares in Q3 2025, an estimated $20.6K.
  • enVVeno Medical made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5544 holding.
  • Wolverine Trading first reported a position in enVVeno Medical in Q2 2025 and has held it in 2 quarters since.
  • Wolverine Trading's enVVeno Medical position peaked at $45.8K in Q2 2025.
  • 36 funds tracked by Wall St. Rank held enVVeno Medical as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.